Rockefeller Capital Management
CNST

Rockefeller Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Rockefeller Capital Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,894
Closed -$569K – 3965
2021
Q2 		$569K Buy
+16,894
New +$431K ﹤0.01% 1153

Rockefeller Capital Management's CNST Position: Q3 2021 in Review

Rockefeller Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 16,894 shares — an estimated $569K sold.

Rockefeller Capital Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $569K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Rockefeller Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Rockefeller Capital Management sold 16,894 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $569K.
  • Rockefeller Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Rockefeller Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $569K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.